date,title,url
2001-03-01,恒瑞医药年报,/disclosure/listedinfo/announcement/c/600276_2000_0.pdf
2001-06-01,恒瑞医药上市公司章程,/disclosure/listedinfo/announcement/c/600276_2001_g.pdf
2001-07-28,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/600276_2001_1.pdf
2001-09-07,恒瑞医药回访报告,/disclosure/listedinfo/announcement/c/600276_20010907_1.pdf
2002-01-29,恒瑞医药上市公司章程,/disclosure/listedinfo/announcement/c/600276_20020129_g.pdf
2002-03-12,恒瑞医药年报,/disclosure/listedinfo/announcement/c/600276_2001_n.pdf
2002-04-23,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/600276_2002_1.pdf
2002-06-21,恒瑞医药回访报告,/disclosure/listedinfo/announcement/c/600276_20020621_1.pdf
2002-06-25,恒瑞医药董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/600276_20020625_4.pdf
2002-06-25,恒瑞医药董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/600276_20020625_1.pdf
2002-06-25,恒瑞医药董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/600276_20020625_3.pdf
2002-06-25,恒瑞医药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/600276_20020625_2.pdf
2002-06-26,恒瑞医药股东大会决议公告,/disclosure/listedinfo/announcement/c/600276_20020626_2.pdf
2002-06-26,恒瑞医药股东大会会议资料,/disclosure/listedinfo/announcement/c/600276_20020626_1.pdf
2002-08-06,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/600276_2002_z.pdf
2002-10-25,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-25/600276_2002_3.pdf
2003-04-22,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2003-04-22/600276_2002_n.pdf
2003-04-22,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-22/600276_2003_1.pdf
2003-06-14,恒瑞医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-06-14/600276_20030614_1.pdf
2003-08-18,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2003-08-18/600276_2003_z.pdf
2003-10-27,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-27/600276_2003_3.pdf
2003-12-02,恒瑞医药股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-12-02/600276_20031202_2.pdf
2003-12-02,恒瑞医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-12-02/600276_20031202_1.pdf
2003-12-03,恒瑞医药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-12-03/600276_20031203_1.pdf
2004-02-18,恒瑞医药总经理工作细则,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_5.pdf
2004-02-18,恒瑞医药召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_3.pdf
2004-02-18,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2004-02-18/600276_2003_n.pdf
2004-02-18,恒瑞医药监事会议事规则,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_6.pdf
2004-02-18,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_2.pdf
2004-02-18,恒瑞医药董事会议事规则,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_4.pdf
2004-02-18,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_1.pdf
2004-02-18,恒瑞医药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-02-18/600276_20040218_7.pdf
2004-03-13,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-13/600276_20040313_2.pdf
2004-03-13,恒瑞医药2003年度会计报表更正公告,/disclosure/listedinfo/announcement/c/2004-03-13/600276_20040313_1.pdf
2004-04-07,恒瑞医药2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-04-07/600276_20040407_1.pdf
2004-04-07,恒瑞医药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-04-07/600276_20040407_3.pdf
2004-04-07,恒瑞医药2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-04-07/600276_20040407_2.pdf
2004-04-16,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-16/600276_2004_1.pdf
2004-05-12,恒瑞医药召开临时股东大会通知,/disclosure/listedinfo/announcement/c/2004-05-12/600276_20040512_5.pdf
2004-05-12,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-05-12/600276_20040512_4.pdf
2004-05-12,恒瑞医药独立董事意见,/disclosure/listedinfo/announcement/c/2004-05-12/600276_20040512_3.pdf
2004-05-12,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-05-12/600276_20040512_1.pdf
2004-05-12,恒瑞医药出售资产公告,/disclosure/listedinfo/announcement/c/2004-05-12/600276_20040512_2.pdf
2004-05-22,恒瑞医药2003年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-05-22/600276_20040522_1.pdf
2004-06-16,恒瑞医药2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-06-16/600276_20040616_1.pdf
2004-06-16,恒瑞医药2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-06-16/600276_20040616_2.pdf
2004-08-10,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-10/600276_20040810_1.pdf
2004-08-10,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-10/600276_2004_zzy.pdf
2004-08-10,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2004-08-10/600276_2004_z.pdf
2004-10-23,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-23/600276_2004_3.pdf
2005-01-25,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2005-01-25/600276_2004_nzy.pdf
2005-01-25,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2005-01-25/600276_2004_n.pdf
2005-01-25,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-01-25/600276_20050125_2.pdf
2005-01-25,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-01-25/600276_20050125_1.pdf
2005-03-01,恒瑞医药2004年年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-03-01/600276_20050301_2.pdf
2005-03-01,恒瑞医药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-03-01/600276_20050301_1.pdf
2005-03-01,恒瑞医药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-03-01/600276_20050301_3.pdf
2005-04-23,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-23/600276_2005_1.pdf
2005-06-10,恒瑞医药2004年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-06-10/600276_20050610_1.pdf
2005-06-15,恒瑞医药2004年度分红派息补充公告,/disclosure/listedinfo/announcement/c/2005-06-15/600276_20050615_1.pdf
2005-07-21,恒瑞医药股权转让公告,/disclosure/listedinfo/announcement/c/2005-07-21/600276_20050721_1.pdf
2005-07-21,恒瑞医药股东增持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-07-21/600276_20050721_2.pdf
2005-07-21,恒瑞医药股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-07-21/600276_20050721_3.pdf
2005-08-09,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-09/600276_2005_zzy.pdf
2005-08-09,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2005-08-09/600276_2005_z.pdf
2005-10-20,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-20/600276_2005_3.pdf
2005-12-28,恒瑞医药股东变更的公告,/disclosure/listedinfo/announcement/c/2005-12-28/600276_20051228_1.pdf
2005-12-29,恒瑞医药股东增持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-12-29/600276_20051229_1.pdf
2006-02-14,恒瑞医药投资成立HENGRUI （USA） LTD 的公告,/disclosure/listedinfo/announcement/c/2006-02-14/600276_20060214_1.pdf
2006-02-24,恒瑞医药收购报告书（摘要）,/disclosure/listedinfo/announcement/c/2006-02-24/600276_20060224_1.pdf
2006-02-24,恒瑞医药国有股权转让的提示公告,/disclosure/listedinfo/announcement/c/2006-02-24/600276_20060224_3.pdf
2006-02-24,恒瑞医药股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2006-02-24/600276_20060224_2.pdf
2006-03-29,恒瑞医药与关联方资金往来的专项说明,/disclosure/listedinfo/announcement/c/2006-03-29/600276_20060329_3.pdf
2006-03-29,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2006-03-29/600276_2005_nzy.pdf
2006-03-29,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2006-03-29/600276_2005_n.pdf
2006-03-29,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-29/600276_20060329_2.pdf
2006-03-29,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-29/600276_20060329_1.pdf
2006-04-19,恒瑞医药关于2005年年度股东大会临时提案的公告,/disclosure/listedinfo/announcement/c/2006-04-19/600276_20060419_1.pdf
2006-04-21,恒瑞医药关于解除公司国有股权转让协议的公告,/disclosure/listedinfo/announcement/c/2006-04-21/600276_20060421_1.pdf
2006-04-21,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-21/600276_2006_1.pdf
2006-04-29,恒瑞医药2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-29/600276_20060429_2.pdf
2006-04-29,恒瑞医药2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-04-29/600276_20060429_1.pdf
2006-05-08,恒瑞医药关于召开公司股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_1.pdf
2006-05-08,恒瑞医药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_4.pdf
2006-05-08,恒瑞医药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_3.pdf
2006-05-08,恒瑞医药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_2.pdf
2006-05-08,恒瑞医药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_5.pdf
2006-05-08,恒瑞医药独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_6.pdf
2006-05-08,恒瑞医药董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2006-05-08/600276_20060508_7.pdf
2006-05-11,恒瑞医药关于举办股权分置改革网上交流会的公告,/disclosure/listedinfo/announcement/c/2006-05-11/600276_20060511_1.pdf
2006-05-17,恒瑞医药关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_1.pdf
2006-05-17,恒瑞医药股权分置改革之补充保荐意见书,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_4.pdf
2006-05-17,恒瑞医药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_3.pdf
2006-05-17,恒瑞医药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_2.pdf
2006-05-17,恒瑞医药股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_5.pdf
2006-05-17,恒瑞医药独立董事关于股权分置改革修订方案之独立意见,/disclosure/listedinfo/announcement/c/2006-05-17/600276_20060517_6.pdf
2006-05-23,恒瑞医药关于股票异常波动的公告,/disclosure/listedinfo/announcement/c/2006-05-23/600276_20060523_1.pdf
2006-05-24,恒瑞医药关于召开相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-05-24/600276_20060524_1.pdf
2006-05-29,恒瑞医药关于召开相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-05-29/600276_20060529_1.pdf
2006-06-05,恒瑞医药股权分置改革相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-05/600276_20060605_2.pdf
2006-06-05,恒瑞医药股权分置改革相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-06-05/600276_20060605_1.pdf
2006-06-15,恒瑞医药股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-06-15/600276_20060615_1.pdf
2006-07-01,G恒瑞实际控制人变化公告,/disclosure/listedinfo/announcement/c/2006-07-01/600276_20060701_1.pdf
2006-07-12,G恒瑞2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-07-12/600276_20060712_1.pdf
2006-07-19,G恒瑞董事会决议公告,/disclosure/listedinfo/announcement/c/2006-07-19/600276_20060719_1.pdf
2006-07-19,G恒瑞半年报摘要,/disclosure/listedinfo/announcement/c/2006-07-19/600276_2006_zzy.pdf
2006-07-19,G恒瑞半年报,/disclosure/listedinfo/announcement/c/2006-07-19/600276_2006_z.pdf
2006-08-17,G恒瑞2006年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-08-17/600276_20060817_1.pdf
2006-08-17,G恒瑞2006年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-08-17/600276_20060817_3.pdf
2006-08-17,G恒瑞2006年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-08-17/600276_20060817_2.pdf
2006-08-23,G恒瑞转增股本实施公告,/disclosure/listedinfo/announcement/c/2006-08-23/600276_20060823_1.pdf
2006-10-20,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-20/600276_2006_3.pdf
2006-11-09,恒瑞医药诉讼公告,/disclosure/listedinfo/announcement/c/2006-11-09/600276_20061109_1.pdf
2007-01-11,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-11/600276_20070111_2.pdf
2007-01-11,恒瑞医药关于召开2007年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-01-11/600276_20070111_5.pdf
2007-01-11,恒瑞医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2007-01-11/600276_20070111_3.pdf
2007-01-11,恒瑞医药独立董事候选人声明,/disclosure/listedinfo/announcement/c/2007-01-11/600276_20070111_4.pdf
2007-01-11,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-11/600276_20070111_1.pdf
2007-01-18,恒瑞医药股票交易价格异常波动公告,/disclosure/listedinfo/announcement/c/2007-01-18/600276_20070118_1.pdf
2007-01-25,恒瑞医药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-01-25/600276_20070125_2.pdf
2007-01-25,恒瑞医药股东变更的公告,/disclosure/listedinfo/announcement/c/2007-01-25/600276_20070125_1.pdf
2007-02-06,恒瑞医药2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-02-06/600276_20070206_1.pdf
2007-02-06,恒瑞医药2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-02-06/600276_20070206_2.pdf
2007-02-08,恒瑞医药与关联方资金往来的专项说明,/disclosure/listedinfo/announcement/c/2007-02-08/600276_20070208_4.pdf
2007-02-08,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2007-02-08/600276_2006_nzy.pdf
2007-02-08,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2007-02-08/600276_2006_n.pdf
2007-02-08,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-02-08/600276_20070208_3.pdf
2007-02-08,恒瑞医药关于召开2006年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-02-08/600276_20070208_2.pdf
2007-02-08,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-02-08/600276_20070208_1.pdf
2007-03-07,恒瑞医药2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-03-07/600276_20070307_2.pdf
2007-03-07,恒瑞医药2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-03-07/600276_20070307_1.pdf
2007-03-27,恒瑞医药2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-03-27/600276_20070327_1.pdf
2007-04-10,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-10/600276_20070410_1.pdf
2007-04-10,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-10/600276_2007_1.pdf
2007-06-13,恒瑞医药诉讼公告,/disclosure/listedinfo/announcement/c/2007-06-13/600276_20070613_1.pdf
2007-06-15,恒瑞医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-06-15/600276_20070615_1.pdf
2007-06-28,恒瑞医药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2007-06-28/600276_20070628_2.pdf
2007-06-28,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-28/600276_20070628_1.pdf
2007-06-30,恒瑞医药关于“加强上市公司治理专项活动”自查情况报告,/disclosure/listedinfo/announcement/c/2007-06-30/600276_20070630_2.pdf
2007-06-30,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600276_20070630_1.pdf
2007-08-08,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-08/600276_2007_zzy.pdf
2007-08-08,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2007-08-08/600276_2007_z.pdf
2007-09-18,恒瑞医药诉讼公告,/disclosure/listedinfo/announcement/c/2007-09-18/600276_20070918_1.pdf
2007-10-09,恒瑞医药2007年1-9月份业绩预增公告,/disclosure/listedinfo/announcement/c/2007-10-09/600276_20071009_1.pdf
2007-10-23,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-23/600276_2007_3.pdf
2007-11-02,恒瑞医药关于股东减持公司股票情况的公告,/disclosure/listedinfo/announcement/c/2007-11-02/600276_20071102_1.pdf
2008-01-08,恒瑞医药2007年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-01-08/600276_20080108_1.pdf
2008-02-28,恒瑞医药与关联方非经营性资金往来及对外违规担保等情况的专项说明,/disclosure/listedinfo/announcement/c/2008-02-28/600276_20080228_4.pdf
2008-02-28,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2008-02-28/600276_2007_nzy.pdf
2008-02-28,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2008-02-28/600276_2007_n.pdf
2008-02-28,恒瑞医药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-28/600276_20080228_3.pdf
2008-02-28,恒瑞医药关于召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-02-28/600276_20080228_2.pdf
2008-02-28,恒瑞医药独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-02-28/600276_20080228_5.pdf
2008-02-28,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-28/600276_20080228_1.pdf
2008-03-22,恒瑞医药2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-03-22/600276_20080322_1.pdf
2008-03-27,恒瑞医药2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-03-27/600276_20080327_1.pdf
2008-03-27,恒瑞医药2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-03-27/600276_20080327_2.pdf
2008-04-07,恒瑞医药2007年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2008-04-07/600276_20080407_1.pdf
2008-04-25,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-25/600276_2008_1.pdf
2008-05-07,恒瑞医药诉讼进展公告,/disclosure/listedinfo/announcement/c/2008-05-07/600276_20080507_1.pdf
2008-06-14,恒瑞医药关于收购连云港华晨医药有限公司股权的公告,/disclosure/listedinfo/announcement/c/2008-06-14/600276_20080614_2.pdf
2008-06-14,恒瑞医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-06-14/600276_20080614_1.pdf
2008-06-14,恒瑞医药变更股改保荐机构的公告,/disclosure/listedinfo/announcement/c/2008-06-14/600276_20080614_3.pdf
2008-06-18,恒瑞医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2008-06-18/600276_20080618_2.pdf
2008-06-18,恒瑞医药变更股改保荐人的公告,/disclosure/listedinfo/announcement/c/2008-06-18/600276_20080618_1.pdf
2008-07-31,恒瑞医药关于公司治理整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-31/600276_20080731_2.pdf
2008-07-31,恒瑞医药第四届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-31/600276_20080731_1.pdf
2008-08-01,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-01/600276_2008_zzy.pdf
2008-08-01,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2008-08-01/600276_2008_z.pdf
2008-10-25,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-25/600276_2008_3.pdf
2008-12-05,恒瑞医药敏感信息排查制度,/disclosure/listedinfo/announcement/c/2008-12-05/600276_20081205_2.pdf
2008-12-05,恒瑞医药第四届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2008-12-05/600276_20081205_1.pdf
2008-12-23,恒瑞医药关于被认定为2008年第二批高新技术企业的公告,/disclosure/listedinfo/announcement/c/2008-12-23/600276_20081223_1.pdf
2009-02-18,恒瑞医药章程修正案,/disclosure/listedinfo/announcement/c/2009-02-18/600276_20090218_2.pdf
2009-02-18,恒瑞医药与关联方资金往来的专项说明,/disclosure/listedinfo/announcement/c/2009-02-18/600276_20090218_5.pdf
2009-02-18,恒瑞医药四届七次监事会决议公告,/disclosure/listedinfo/announcement/c/2009-02-18/600276_20090218_4.pdf
2009-02-18,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2009-02-18/600276_2008_nzy.pdf
2009-02-18,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2009-02-18/600276_2008_n.pdf
2009-02-18,恒瑞医药关于召开2008年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-02-18/600276_20090218_3.pdf
2009-02-18,恒瑞医药第四届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2009-02-18/600276_20090218_1.pdf
2009-03-27,恒瑞医药2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-27/600276_20090327_1.pdf
2009-03-31,恒瑞医药2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-31/600276_20090331_1.pdf
2009-03-31,恒瑞医药2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-31/600276_20090331_2.pdf
2009-04-21,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-21/600276_2009_1.pdf
2009-04-24,恒瑞医药2008年利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-04-24/600276_20090424_1.pdf
2009-04-29,恒瑞医药2008年利润分配实施更正公告,/disclosure/listedinfo/announcement/c/2009-04-29/600276_20090429_1.pdf
2009-06-17,恒瑞医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2009-06-17/600276_20090617_1.pdf
2009-08-05,恒瑞医药公告,/disclosure/listedinfo/announcement/c/2009-08-05/600276_20090805_1.pdf
2009-08-13,恒瑞医药股东减持公告,/disclosure/listedinfo/announcement/c/2009-08-13/600276_20090813_1.pdf
2009-08-20,恒瑞医药自主研发的创新药在美国开始临床试验的公告,/disclosure/listedinfo/announcement/c/2009-08-20/600276_20090820_1.pdf
2009-08-26,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-26/600276_2009_zzy.pdf
2009-08-26,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2009-08-26/600276_2009_z.pdf
2009-10-23,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-23/600276_2009_3.pdf
2010-01-27,恒瑞医药2009年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-01-27/600276_20100127_1.pdf
2010-02-08,恒瑞医药与关联方资金往来的专项说明,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_4.pdf
2010-02-08,恒瑞医药四届十一次监事会决议公告,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_3.pdf
2010-02-08,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2010-02-08/600276_2009_nzy.pdf
2010-02-08,恒瑞医药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_6.pdf
2010-02-08,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2010-02-08/600276_2009_n.pdf
2010-02-08,恒瑞医药内幕信息及知情人管理备案制度,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_5.pdf
2010-02-08,恒瑞医药关于召开2009年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_2.pdf
2010-02-08,恒瑞医药第四届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2010-02-08/600276_20100208_1.pdf
2010-02-26,恒瑞医药2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-02-26/600276_20100226_1.pdf
2010-03-02,恒瑞医药2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-03-02/600276_20100302_1.pdf
2010-03-02,恒瑞医药2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-03-02/600276_20100302_2.pdf
2010-03-10,恒瑞医药2009年利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-03-10/600276_20100310_1.pdf
2010-03-27,恒瑞医药四届十二次监事会决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600276_20100327_2.pdf
2010-03-27,恒瑞医药关于召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-27/600276_20100327_3.pdf
2010-03-27,恒瑞医药第四届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600276_20100327_1.pdf
2010-03-31,恒瑞医药关于成立连云港置业有限公司的公告,/disclosure/listedinfo/announcement/c/2010-03-31/600276_20100331_1.pdf
2010-04-03,恒瑞医药2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-03/600276_20100403_1.pdf
2010-04-09,恒瑞医药停牌公告,/disclosure/listedinfo/announcement/c/2010-04-09/600276_20100409_1.pdf
2010-04-13,恒瑞医药限制性股票激励计划实施考核办法,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_9.pdf
2010-04-13,恒瑞医药高级管理人员提名即聘任程序的独立董事意见,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_3.pdf
2010-04-13,恒瑞医药独立董事关于公司A股限制性股票激励计划（草案）的独立意见,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_5.pdf
2010-04-13,恒瑞医药第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_6.pdf
2010-04-13,恒瑞医药第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_2.pdf
2010-04-13,恒瑞医药A股限制性股票激励计划（摘要）,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_4.pdf
2010-04-13,恒瑞医药A股限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_7.pdf
2010-04-13,恒瑞医药2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_1.pdf
2010-04-13,恒瑞医药2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-13/600276_20100413_8.pdf
2010-04-20,恒瑞医药捐赠公告,/disclosure/listedinfo/announcement/c/2010-04-20/600276_20100420_1.pdf
2010-04-22,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-22/600276_2010_1.pdf
2010-06-09,恒瑞医药股权激励进展公告,/disclosure/listedinfo/announcement/c/2010-06-09/600276_20100609_1.pdf
2010-06-10,恒瑞医药关于召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_4.pdf
2010-06-10,恒瑞医药独立董事公开征集委托投票权报告书,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_3.pdf
2010-06-10,恒瑞医药第五届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_5.pdf
2010-06-10,恒瑞医药第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_1.pdf
2010-06-10,恒瑞医药A股限制性股票激励计划（修订稿摘要）,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_2.pdf
2010-06-10,恒瑞医药A股限制性股票激励计划（草案修订稿）,/disclosure/listedinfo/announcement/c/2010-06-10/600276_20100610_6.pdf
2010-06-17,恒瑞医药关于召开2010年第一次临时股东大会通知的提示性公告,/disclosure/listedinfo/announcement/c/2010-06-17/600276_20100617_1.pdf
2010-06-19,恒瑞医药更正公告,/disclosure/listedinfo/announcement/c/2010-06-19/600276_20100619_1.pdf
2010-06-22,恒瑞医药2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-06-22/600276_20100622_1.pdf
2010-06-29,恒瑞医药2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-06-29/600276_20100629_1.pdf
2010-06-29,恒瑞医药2010年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-06-29/600276_20100629_2.pdf
2010-06-30,恒瑞医药独立董事就公司限制性股票激励计划相关事项发表的意见,/disclosure/listedinfo/announcement/c/2010-06-30/600276_20100630_2.pdf
2010-06-30,恒瑞医药第五届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-30/600276_20100630_1.pdf
2010-07-23,恒瑞医药独立董事就部分激励对象放弃或减少认购A股限制性股票所发表的意见,/disclosure/listedinfo/announcement/c/2010-07-23/600276_20100723_3.pdf
2010-07-23,恒瑞医药第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-07-23/600276_20100723_2.pdf
2010-07-23,恒瑞医药第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-07-23/600276_20100723_1.pdf
2010-07-29,恒瑞医药限制性股票授予完成的公告,/disclosure/listedinfo/announcement/c/2010-07-29/600276_20100729_1.pdf
2010-08-04,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2010-08-04/600276_20100804_1.pdf
2010-08-06,恒瑞医药关于成立连云港置业有限公司的公告,/disclosure/listedinfo/announcement/c/2010-08-06/600276_20100806_1.pdf
2010-08-07,恒瑞医药副总经理提名及聘任程序的独立董事意见,/disclosure/listedinfo/announcement/c/2010-08-07/600276_20100807_2.pdf
2010-08-07,恒瑞医药董事、监事及高管人员持股及变动管理制度,/disclosure/listedinfo/announcement/c/2010-08-07/600276_20100807_3.pdf
2010-08-07,恒瑞医药第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-07/600276_20100807_1.pdf
2010-08-07,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-07/600276_2010_zzy.pdf
2010-08-07,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2010-08-07/600276_2010_z.pdf
2010-10-30,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-30/600276_2010_3.pdf
2010-11-17,恒瑞医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-11-17/600276_20101117_1.pdf
2010-12-10,恒瑞医药第五届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2010-12-10/600276_20101210_1.pdf
2011-02-11,恒瑞医药关于达宁退市的公告,/disclosure/listedinfo/announcement/c/2011-02-11/600276_20110211_1.pdf
2011-03-02,恒瑞医药与关联方资金往来的专项说明,/disclosure/listedinfo/announcement/c/2011-03-02/600276_20110302_4.pdf
2011-03-02,恒瑞医药五届七次监事会决议公告,/disclosure/listedinfo/announcement/c/2011-03-02/600276_20110302_3.pdf
2011-03-02,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2011-03-02/600276_2010_nzy.pdf
2011-03-02,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2011-03-02/600276_2010_n.pdf
2011-03-02,恒瑞医药关于召开2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-03-02/600276_20110302_2.pdf
2011-03-02,恒瑞医药第五届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-02/600276_20110302_1.pdf
2011-03-12,恒瑞医药2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-03-12/600276_20110312_1.pdf
2011-03-26,恒瑞医药2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-03-26/600276_20110326_1.pdf
2011-03-26,恒瑞医药2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-03-26/600276_20110326_2.pdf
2011-04-19,恒瑞医药2010年度利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2011-04-19/600276_20110419_1.pdf
2011-04-25,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-25/600276_2011_1.pdf
2011-06-15,恒瑞医药关于艾瑞昔布获得国家一类新药批件及证书的公告,/disclosure/listedinfo/announcement/c/2011-06-15/600276_20110615_2.pdf
2011-06-15,恒瑞医药第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-06-15/600276_20110615_1.pdf
2011-07-06,恒瑞医药关于股权激励股票首次解锁的公告,/disclosure/listedinfo/announcement/c/2011-07-06/600276_20110706_1.pdf
2011-08-06,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-06/600276_2011_zzy.pdf
2011-08-06,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2011-08-06/600276_2011_z.pdf
2011-10-28,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-28/600276_2011_3.pdf
2011-11-02,恒瑞医药关于公司董事买卖公司股票的公告,/disclosure/listedinfo/announcement/c/2011-11-02/600276_20111102_1.pdf
2011-12-20,恒瑞医药关于伊立替康注射液通过美国FDA认证的公告,/disclosure/listedinfo/announcement/c/2011-12-20/600276_20111220_1.pdf
2012-02-11,恒瑞医药关于收购北京恒森创新医药科技有限公司的公告,/disclosure/listedinfo/announcement/c/2012-02-11/600276_20120211_1.pdf
2012-03-20,恒瑞医药五届十一次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_3.pdf
2012-03-20,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2012-03-20/600276_2011_nzy.pdf
2012-03-20,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2012-03-20/600276_2011_n.pdf
2012-03-20,恒瑞医药关于召开2011年度股东大会的议案,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_2.pdf
2012-03-20,恒瑞医药关于董事及独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_4.pdf
2012-03-20,恒瑞医药独立董事2011年述职报告,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_6.pdf
2012-03-20,恒瑞医药第五届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_1.pdf
2012-03-20,恒瑞医药2011年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2012-03-20/600276_20120320_5.pdf
2012-03-31,恒瑞医药五届十六次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-03-31/600276_20120331_1.pdf
2012-03-31,恒瑞医药实施内部控制规范工作方案,/disclosure/listedinfo/announcement/c/2012-03-31/600276_20120331_2.pdf
2012-03-31,恒瑞医药2011年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-03-31/600276_20120331_3.pdf
2012-04-12,恒瑞医药五届十七次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-04-12/600276_20120412_2.pdf
2012-04-12,恒瑞医药2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-12/600276_20120412_1.pdf
2012-04-12,恒瑞医药2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-04-12/600276_20120412_3.pdf
2012-04-27,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-27/600276_2012_1.pdf
2012-05-18,恒瑞医药关于独资设立成都新越医药有限公司的公告,/disclosure/listedinfo/announcement/c/2012-05-18/600276_20120518_1.pdf
2012-05-22,恒瑞医药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-05-22/600276_20120522_1.pdf
2012-07-02,恒瑞医药关于股权激励股票第二次解锁的公告,/disclosure/listedinfo/announcement/c/2012-07-02/600276_20120702_1.pdf
2012-08-10,恒瑞医药五届十三次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-08-10/600276_20120810_4.pdf
2012-08-10,恒瑞医药关于召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-08-10/600276_20120810_3.pdf
2012-08-10,恒瑞医药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2012-08-10/600276_20120810_2.pdf
2012-08-10,恒瑞医药第五届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-10/600276_20120810_1.pdf
2012-08-10,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-10/600276_2012_zzy.pdf
2012-08-10,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2012-08-10/600276_2012_z.pdf
2012-08-18,恒瑞医药2012年第一次临时股东大会资料,/disclosure/listedinfo/announcement/c/2012-08-18/600276_20120818_1.pdf
2012-08-24,恒瑞医药注射用奥沙利铂获准在欧盟上市销售的公告,/disclosure/listedinfo/announcement/c/2012-08-24/600276_20120824_1.pdf
2012-08-30,恒瑞医药五届二十二次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-08-30/600276_20120830_2.pdf
2012-08-30,恒瑞医药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-08-30/600276_20120830_1.pdf
2012-08-30,恒瑞医药2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-08-30/600276_20120830_3.pdf
2012-10-27,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-27/600276_2012_3.pdf
2013-02-21,恒瑞医药关于2012年度利润分配预案征求投资者意见的公告,/disclosure/listedinfo/announcement/c/2013-02-20/600276_20130221_1.pdf
2013-03-16,恒瑞医药实施内部控制规范工作方案,/disclosure/listedinfo/announcement/c/2013-03-15/600276_20130316_2.pdf
2013-03-16,恒瑞医药关联交易管理办法,/disclosure/listedinfo/announcement/c/2013-03-15/600276_20130316_3.pdf
2013-03-16,恒瑞医药第五届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-15/600276_20130316_1.pdf
2013-04-02,恒瑞医药审计报告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_13.pdf
2013-04-02,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2013-04-01/600276_2012_nzy.pdf
2013-04-02,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2013-04-01/600276_2012_n.pdf
2013-04-02,恒瑞医药会计估计变更的说明,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_10.pdf
2013-04-02,恒瑞医药关于召开2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_7.pdf
2013-04-02,恒瑞医药关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_5.pdf
2013-04-02,恒瑞医药关于成都盛迪医药有限公司增资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_6.pdf
2013-04-02,恒瑞医药独立董事事前认可声明,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_16.pdf
2013-04-02,恒瑞医药独立董事关于预计2013年度日常关联交易的独立意见,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_14.pdf
2013-04-02,恒瑞医药独立董事关于成都盛迪医药有限公司增资暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_17.pdf
2013-04-02,恒瑞医药董事会审计委员会书面审核意见,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_15.pdf
2013-04-02,恒瑞医药第五届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_4.pdf
2013-04-02,恒瑞医药第五届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_3.pdf
2013-04-02,恒瑞医药2012年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_12.pdf
2013-04-02,恒瑞医药2012年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_9.pdf
2013-04-02,恒瑞医药2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-04-01/600276_20130402_11.pdf
2013-04-09,恒瑞医药2012年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-04-08/600276_20130409_1.pdf
2013-04-10,恒瑞医药关于召开2012年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2013-04-09/600276_20130410_2.pdf
2013-04-10,恒瑞医药关于召开2012年度股东大会通知的更正公告,/disclosure/listedinfo/announcement/c/2013-04-09/600276_20130410_1.pdf
2013-04-25,恒瑞医药独立董事关于高级管理人员提名及聘任程序的独立意见,/disclosure/listedinfo/announcement/c/2013-04-24/600276_20130425_6.pdf
2013-04-25,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600276_2013_1.pdf
2013-04-25,恒瑞医药第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600276_20130425_4.pdf
2013-04-25,恒瑞医药第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600276_20130425_3.pdf
2013-04-25,恒瑞医药2012年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-04-24/600276_20130425_5.pdf
2013-04-25,恒瑞医药2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600276_20130425_2.pdf
2013-05-18,恒瑞医药关于来曲唑片通过美国FDA认证的公告,/disclosure/listedinfo/announcement/c/2013-05-17/600276_20130518_1.pdf
2013-06-03,恒瑞医药2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-06-02/600276_20130603_1.pdf
2013-07-02,恒瑞医药监事会关于公司股权激励股票第三次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2013-07-01/600276_20130702_4.pdf
2013-07-02,恒瑞医药关于股权激励股票第三次解锁的公告,/disclosure/listedinfo/announcement/c/2013-07-01/600276_20130702_1.pdf
2013-07-02,恒瑞医药股权激励计划之限制性股票第三次解锁事宜的法律意见,/disclosure/listedinfo/announcement/c/2013-07-01/600276_20130702_3.pdf
2013-07-02,恒瑞医药独立董事关于股权激励股票符合第三次解锁条件的独立意见,/disclosure/listedinfo/announcement/c/2013-07-01/600276_20130702_2.pdf
2013-08-17,恒瑞医药独立董事关于高级管理人员提名及聘任程序的独立意见,/disclosure/listedinfo/announcement/c/2013-08-16/600276_20130817_4.pdf
2013-08-17,恒瑞医药第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-16/600276_20130817_2.pdf
2013-08-17,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-16/600276_2013_zzy.pdf
2013-08-17,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2013-08-16/600276_2013_z.pdf
2013-10-10,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2013-10-09/600276_20131010_1.pdf
2013-10-29,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-28/600276_2013_3.pdf
2014-02-15,恒瑞医药关于会计师事务所转制更名的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600276_20140215_1.pdf
2014-03-04,恒瑞医药独立董事关于聘任公司常务副总经理的独立意见,/disclosure/listedinfo/announcement/c/2014-03-03/600276_20140304_2.pdf
2014-03-04,恒瑞医药第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-03/600276_20140304_1.pdf
2014-03-11,恒瑞医药关于2013年度利润分配预案征求投资者意见的公告,/disclosure/listedinfo/announcement/c/2014-03-10/600276_20140311_1.pdf
2014-04-09,恒瑞医药限制性股票激励计划实施考核管理办法,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_18.pdf
2014-04-09,恒瑞医药限制性股票激励计划（草案）摘要公告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_2.pdf
2014-04-09,恒瑞医药审计委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_14.pdf
2014-04-09,恒瑞医药审计报告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_8.pdf
2014-04-09,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2014-04-08/600276_2013_nzy.pdf
2014-04-09,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2014-04-08/600276_2013_n.pdf
2014-04-09,恒瑞医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_12.pdf
2014-04-09,恒瑞医药关于召开2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_4.pdf
2014-04-09,恒瑞医药关于更换财务总监的公告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_6.pdf
2014-04-09,恒瑞医药独立董事关于第六届董事会第六次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_15.pdf
2014-04-09,恒瑞医药第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_5.pdf
2014-04-09,恒瑞医药第六届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_3.pdf
2014-04-09,恒瑞医药：关于江苏恒瑞医药股份有限公司2013年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_9.pdf
2014-04-09,恒瑞医药：北京市君泽君律师事务所关于《江苏恒瑞医药股份有限公司限制性股票激励计划（草案）》的法律意见,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_16.pdf
2014-04-09,恒瑞医药2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_11.pdf
2014-04-09,恒瑞医药2013年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2014-04-08/600276_20140409_10.pdf
2014-04-10,恒瑞医药限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2014-04-09/600276_20140410_1.pdf
2014-04-10,恒瑞医药关于召开2013年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2014-04-09/600276_20140410_2.pdf
2014-04-16,恒瑞医药2013年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-04-15/600276_20140416_1.pdf
2014-04-28,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-27/600276_2014_1.pdf
2014-05-01,恒瑞医药2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-04-30/600276_20140501_2.pdf
2014-05-01,恒瑞医药2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-04-30/600276_20140501_1.pdf
2014-05-06,恒瑞医药关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-05-05/600276_20140506_2.pdf
2014-05-06,恒瑞医药关于独立董事公开征集投票权的公告,/disclosure/listedinfo/announcement/c/2014-05-05/600276_20140506_1.pdf
2014-05-09,恒瑞医药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-05-08/600276_20140509_1.pdf
2014-05-10,恒瑞医药2014年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-09/600276_20140510_1.pdf
2014-05-23,恒瑞医药独立董事关于公司限制性股票激励计划授予事项的独立意见,/disclosure/listedinfo/announcement/c/2014-05-22/600276_20140523_5.pdf
2014-05-23,恒瑞医药第六届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-22/600276_20140523_2.pdf
2014-05-23,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司限制性股票授予事项的法律意见,/disclosure/listedinfo/announcement/c/2014-05-22/600276_20140523_4.pdf
2014-05-23,恒瑞医药2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-22/600276_20140523_1.pdf
2014-05-23,恒瑞医药2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-22/600276_20140523_3.pdf
2014-05-24,恒瑞医药限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2014-05-23/600276_20140524_2.pdf
2014-05-24,恒瑞医药关于限制性股票激励计划授予事项的公告,/disclosure/listedinfo/announcement/c/2014-05-23/600276_20140524_1.pdf
2014-06-07,恒瑞医药关于阿帕替尼开发进展的公告,/disclosure/listedinfo/announcement/c/2014-06-06/600276_20140607_1.pdf
2014-06-24,恒瑞医药关于注射用奥沙利铂通过美国FDA认证的公告,/disclosure/listedinfo/announcement/c/2014-06-23/600276_20140624_1.pdf
2014-07-18,恒瑞医药股权激励计划限制性股票授予结果公告,/disclosure/listedinfo/announcement/c/2014-07-17/600276_20140718_1.pdf
2014-07-22,恒瑞医药重大信息内部报告制度,/disclosure/listedinfo/announcement/c/2014-07-21/600276_20140722_2.pdf
2014-07-22,恒瑞医药风险投资管理制度,/disclosure/listedinfo/announcement/c/2014-07-21/600276_20140722_3.pdf
2014-07-22,恒瑞医药第六届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-21/600276_20140722_1.pdf
2014-08-16,恒瑞医药关于为成都盛迪医药有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2014-08-15/600276_20140816_1.pdf
2014-08-16,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-15/600276_2014_zzy.pdf
2014-08-16,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2014-08-15/600276_2014_z.pdf
2014-08-27,恒瑞医药关于控股股东名称变更的公告,/disclosure/listedinfo/announcement/c/2014-08-26/600276_20140827_1.pdf
2014-10-28,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-27/600276_2014_3.pdf
2014-11-05,恒瑞医药关于阿帕替尼获得国家1.1类新药批件及证书的公告,/disclosure/listedinfo/announcement/c/2014-11-04/600276_20141105_1.pdf
2014-11-11,恒瑞医药关于注射用环磷酰胺在美国上市销售的公告,/disclosure/listedinfo/announcement/c/2014-11-10/600276_20141111_1.pdf
2014-11-12,恒瑞医药关于在德国设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2014-11-11/600276_20141112_1.pdf
2014-12-09,恒瑞医药关于美国检方撤销对我公司曹国庆博士全部指控的公告,/disclosure/listedinfo/announcement/c/2014-12-08/600276_20141209_1.pdf
2014-12-17,恒瑞医药关于公司股东减持股份后持股比例低于5%的提示性公告,/disclosure/listedinfo/announcement/c/2014-12-16/600276_20141217_1.pdf
2014-12-24,恒瑞医药第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-23/600276_20141224_1.pdf
2014-12-27,恒瑞医药限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2014-12-26/600276_20141227_4.pdf
2014-12-27,恒瑞医药关于部分限制性股票激励计划授予事项的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600276_20141227_1.pdf
2014-12-27,恒瑞医药独立董事关于部分限制性股票激励计划授予事项的独立意见,/disclosure/listedinfo/announcement/c/2014-12-26/600276_20141227_2.pdf
2014-12-27,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司部分限制性股票授予的法律意见,/disclosure/listedinfo/announcement/c/2014-12-26/600276_20141227_3.pdf
2015-01-17,恒瑞医药验资报告,/disclosure/listedinfo/announcement/c/2015-01-16/600276_20150117_2.pdf
2015-01-17,恒瑞医药股权激励计划部分限制性股票授予结果公告,/disclosure/listedinfo/announcement/c/2015-01-16/600276_20150117_1.pdf
2015-03-14,恒瑞医药关于公司股东累计减持比例达到1%的公告,/disclosure/listedinfo/announcement/c/2015-03-13/600276_20150314_1.pdf
2015-03-31,恒瑞医药审计委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_12.pdf
2015-03-31,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2015-03-30/600276_2014_nzy.pdf
2015-03-31,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2015-03-30/600276_2014_n.pdf
2015-03-31,恒瑞医药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_3.pdf
2015-03-31,恒瑞医药关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_2.pdf
2015-03-31,恒瑞医药独立董事关于第六届董事会第十四次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_13.pdf
2015-03-31,恒瑞医药第六届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_5.pdf
2015-03-31,恒瑞医药第六届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_4.pdf
2015-03-31,恒瑞医药：关于公司2014年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_8.pdf
2015-03-31,恒瑞医药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_7.pdf
2015-03-31,恒瑞医药2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_11.pdf
2015-03-31,恒瑞医药2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_10.pdf
2015-03-31,恒瑞医药2014年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2015-03-30/600276_20150331_9.pdf
2015-04-01,恒瑞医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-03-31/600276_20150401_3.pdf
2015-04-01,恒瑞医药独立董事候选人声明,/disclosure/listedinfo/announcement/c/2015-03-31/600276_20150401_2.pdf
2015-04-01,恒瑞医药第六届董事会第十四次会议决议补充公告,/disclosure/listedinfo/announcement/c/2015-03-31/600276_20150401_1.pdf
2015-04-02,恒瑞医药章程修正案,/disclosure/listedinfo/announcement/c/2015-04-01/600276_20150402_2.pdf
2015-04-02,恒瑞医药关于2014年年度股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2015-04-01/600276_20150402_1.pdf
2015-04-02,恒瑞医药公司章程,/disclosure/listedinfo/announcement/c/2015-04-01/600276_20150402_3.pdf
2015-04-03,恒瑞医药关于召开2014年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2015-04-02/600276_20150403_3.pdf
2015-04-03,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2015-04-02/600276_20150403_1.pdf
2015-04-03,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2015-04-02/600276_20150403_2.pdf
2015-04-03,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2015-04-02/600276_20150403_4.pdf
2015-04-11,恒瑞医药2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-04-10/600276_20150411_1.pdf
2015-04-18,恒瑞医药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-17/600276_2015_1.pdf
2015-05-07,恒瑞医药第六届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-06/600276_20150507_2.pdf
2015-05-07,恒瑞医药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-06/600276_20150507_1.pdf
2015-05-07,恒瑞医药2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-06/600276_20150507_3.pdf
2015-05-27,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2015-05-26/600276_20150527_1.pdf
2015-06-09,恒瑞医药2014年度利润分配及资本公积转增股本实施公告,/disclosure/listedinfo/announcement/c/2015-06-08/600276_20150609_1.pdf
2015-07-14,恒瑞医药监事会关于部分股权激励股票第一次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_6.pdf
2015-07-14,恒瑞医药关于在苏州设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_3.pdf
2015-07-14,恒瑞医药关于部分股权激励股票第一次解锁的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_1.pdf
2015-07-14,恒瑞医药独立董事关于第六届董事会第十七次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_5.pdf
2015-07-14,恒瑞医药第六届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_2.pdf
2015-07-14,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司限制性股票激励计划解锁事项的法律意见,/disclosure/listedinfo/announcement/c/2015-07-13/600276_20150714_4.pdf
2015-07-31,恒瑞医药关于引进美国Tesaro公司产品的公告,/disclosure/listedinfo/announcement/c/2015-07-30/600276_20150731_1.pdf
2015-08-12,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2015-08-12/600276_20150812_1.pdf
2015-08-25,恒瑞医药关于注射用伊立替康通过日本认证的公告,/disclosure/listedinfo/announcement/c/2015-08-25/600276_20150825_3.pdf
2015-08-25,恒瑞医药独立董事关于提名及聘任公司副总经理的独立意见,/disclosure/listedinfo/announcement/c/2015-08-25/600276_20150825_5.pdf
2015-08-25,恒瑞医药第六届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-25/600276_20150825_2.pdf
2015-08-25,恒瑞医药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-25/600276_2015_zzy.pdf
2015-08-25,恒瑞医药半年报,/disclosure/listedinfo/announcement/c/2015-08-25/600276_2015_z.pdf
2015-09-03,恒瑞医药关于许可美国 Incyte 公司在国外开发和销售 PD-1 抗体的公告,/disclosure/listedinfo/announcement/c/2015-09-03/600276_20150903_1.pdf
2015-09-09,恒瑞医药关于设立创业投资合伙企业的公告,/disclosure/listedinfo/announcement/c/2015-09-09/600276_20150909_1.pdf
2015-09-11,恒瑞医药关于设立创业投资合伙企业的补充公告,/disclosure/listedinfo/announcement/c/2015-09-11/600276_20150911_1.pdf
2015-09-12,恒瑞医药关于连云港生物医药项目投资计划的公告,/disclosure/listedinfo/announcement/c/2015-09-12/600276_20150912_1.pdf
2015-10-01,恒瑞医药提示性公告,/disclosure/listedinfo/announcement/c/2015-10-01/600276_20151001_1.pdf
2015-10-01,恒瑞医药简式权益变动报告书（西藏达孜汇鑫投资管理合伙企业（有限合伙））,/disclosure/listedinfo/announcement/c/2015-10-01/600276_20151001_3.pdf
2015-10-01,恒瑞医药简式权益变动报告书（西藏达孜达远投资有限公司）,/disclosure/listedinfo/announcement/c/2015-10-01/600276_20151001_2.pdf
2015-10-28,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_4.pdf
2015-10-28,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_5.pdf
2015-10-28,恒瑞医药独立董事关于回购注销部分已授出股权激励股票的独立意见,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_8.pdf
2015-10-28,恒瑞医药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/600276_2015_3.pdf
2015-10-28,恒瑞医药第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_3.pdf
2015-10-28,恒瑞医药第六届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_2.pdf
2015-10-28,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2015-10-28/600276_20151028_6.pdf
2015-11-11,恒瑞医药关于吸入用七氟烷通过美国FDA认证的公告,/disclosure/listedinfo/announcement/c/2015-11-11/600276_20151111_1.pdf
2015-11-16,恒瑞医药关于吸入用七氟烷通过美国FDA认证的补充公告,/disclosure/listedinfo/announcement/c/2015-11-16/600276_20151116_1.pdf
2015-12-02,恒瑞医药关于吸入用七氟烷通过美国FDA认证的补充公告,/disclosure/listedinfo/announcement/c/2015-12-02/600276_20151202_1.pdf
2015-12-04,恒瑞医药关于撤回盐酸伊伐布雷定注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-04/600276_20151204_1.pdf
2015-12-17,恒瑞医药关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2015-12-17/600276_20151217_1.pdf
2015-12-19,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2015-12-19/600276_20151219_1.pdf
2015-12-26,恒瑞医药关于收到上海证券交易所进一步问询函及回复的公告,/disclosure/listedinfo/announcement/c/2015-12-26/600276_20151226_1.pdf
2016-01-08,恒瑞医药关于撤回药品注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-08/600276_20160108_1.pdf
2016-01-16,恒瑞医药监事会关于部分股权激励股票第一次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2016-01-16/600276_20160116_3.pdf
2016-01-16,恒瑞医药关于部分股权激励股票第一次解锁的公告,/disclosure/listedinfo/announcement/c/2016-01-16/600276_20160116_1.pdf
2016-01-16,恒瑞医药独立董事关于公司部分股权激励股票第一次解锁的独立意见,/disclosure/listedinfo/announcement/c/2016-01-16/600276_20160116_4.pdf
2016-01-16,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司部分股权激励股票第一次解锁的法律意见,/disclosure/listedinfo/announcement/c/2016-01-16/600276_20160116_2.pdf
2016-01-22,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-01-22/600276_20160122_1.pdf
2016-01-22,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2016-01-22/600276_20160122_2.pdf
2016-01-26,恒瑞医药关于撤回盐酸右氯胺酮药品注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-26/600276_20160126_1.pdf
2016-02-20,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-02-20/600276_20160220_1.pdf
2016-03-09,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-09/600276_20160309_1.pdf
2016-03-10,恒瑞医药关于药品注册进度的提示性公告,/disclosure/listedinfo/announcement/c/2016-03-10/600276_20160310_1.pdf
2016-03-19,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600276_20160319_1.pdf
2016-03-26,恒瑞医药关于获得药物临床试验批件和药品注册批件的公告,/disclosure/listedinfo/announcement/c/2016-03-26/600276_20160326_1.pdf
2016-04-08,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600276_20160408_1.pdf
2016-04-08,恒瑞医药关于撤回磷酸瑞格列汀及片注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-08/600276_20160408_2.pdf
2016-04-13,恒瑞医药章程修正案的公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_7.pdf
2016-04-13,恒瑞医药审计委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_16.pdf
2016-04-13,恒瑞医药审计报告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_11.pdf
2016-04-13,恒瑞医药年报摘要,/disclosure/listedinfo/announcement/c/2016-04-13/600276_2015_nzy.pdf
2016-04-13,恒瑞医药年报,/disclosure/listedinfo/announcement/c/2016-04-13/600276_2015_n.pdf
2016-04-13,恒瑞医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_15.pdf
2016-04-13,恒瑞医药关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_8.pdf
2016-04-13,恒瑞医药关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_6.pdf
2016-04-13,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_4.pdf
2016-04-13,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_5.pdf
2016-04-13,恒瑞医药关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_26.pdf
2016-04-13,恒瑞医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_25.pdf
2016-04-13,恒瑞医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_22.pdf
2016-04-13,恒瑞医药独立董事候选人声明（薛爽）,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_20.pdf
2016-04-13,恒瑞医药独立董事候选人声明（王迁）,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_19.pdf
2016-04-13,恒瑞医药独立董事候选人声明（李援朝）,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_21.pdf
2016-04-13,恒瑞医药独立董事关于第六届董事会第二十二次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_10.pdf
2016-04-13,恒瑞医药独立董事关于第六届董事会第二十二次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_18.pdf
2016-04-13,恒瑞医药独立董事关于第六届董事会第二十二次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_24.pdf
2016-04-13,恒瑞医药第六届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_3.pdf
2016-04-13,恒瑞医药第六届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_2.pdf
2016-04-13,恒瑞医药：关于江苏恒瑞医药股份有限公司2015年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_12.pdf
2016-04-13,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_17.pdf
2016-04-13,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_23.pdf
2016-04-13,恒瑞医药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_14.pdf
2016-04-13,恒瑞医药2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-04-13/600276_20160413_13.pdf
2016-04-19,恒瑞医药关于子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-04-19/600276_20160419_2.pdf
2016-04-19,恒瑞医药关于召开2015年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2016-04-19/600276_20160419_1.pdf
2016-04-26,恒瑞医药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-26/600276_2016_1.pdf
2016-04-28,恒瑞医药2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-04-28/600276_20160428_1.pdf
2016-04-30,恒瑞医药关于子公司认购私募基金份额的公告,/disclosure/listedinfo/announcement/c/2016-04-30/600276_20160430_1.pdf
2016-04-30,恒瑞医药关于子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-04-30/600276_20160430_3.pdf
2016-04-30,恒瑞医药关于撤回药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-04-30/600276_20160430_2.pdf
2016-05-11,恒瑞医药关于公司董事会秘书变更的公告,/disclosure/listedinfo/announcement/c/2016-05-11/600276_20160511_4.pdf
2016-05-11,恒瑞医药第七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-11/600276_20160511_3.pdf
2016-05-11,恒瑞医药第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-11/600276_20160511_2.pdf
2016-05-11,恒瑞医药2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-11/600276_20160511_1.pdf
2016-05-11,恒瑞医药2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-05-11/600276_20160511_5.pdf
2016-05-19,恒瑞医药关于撤回药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-05-19/600276_20160519_1.pdf
2016-05-27,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-27/600276_20160527_1.pdf
2016-06-08,恒瑞医药2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-06-08/600276_20160608_1.pdf
2016-07-05,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-07-05/600276_20160705_1.pdf
2016-07-13,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_3.pdf
2016-07-13,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_5.pdf
2016-07-13,恒瑞医药关于调整限制性股票回购数量及回购价格的公告,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_4.pdf
2016-07-13,恒瑞医药独立董事关于第七届董事会第三次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_6.pdf
2016-07-13,恒瑞医药第七届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_2.pdf
2016-07-13,恒瑞医药第七届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_1.pdf
2016-07-13,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励相关事项的法律意见,/disclosure/listedinfo/announcement/c/2016-07-13/600276_20160713_7.pdf
2016-07-14,恒瑞医药监事会关于部分股权激励股票第二次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2016-07-14/600276_20160714_4.pdf
2016-07-14,恒瑞医药关于部分股权激励股票第二次解锁的公告,/disclosure/listedinfo/announcement/c/2016-07-14/600276_20160714_1.pdf
2016-07-14,恒瑞医药独立董事关于第七届董事会第三次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-14/600276_20160714_3.pdf
2016-07-14,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励相关事项的法律意见,/disclosure/listedinfo/announcement/c/2016-07-14/600276_20160714_2.pdf
2016-08-03,恒瑞医药关于公司及控股子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2016-08-03/600276_20160803_1.pdf
2016-08-20,恒瑞医药关于子公司获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600276_20160820_1.pdf
2016-08-24,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-24/600276_20160824_1.pdf
2016-08-30,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_4.pdf
2016-08-30,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_5.pdf
2016-08-30,恒瑞医药独立董事关于回购注销部分已授出股权激励股票的独立意见,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_7.pdf
2016-08-30,恒瑞医药第七届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_3.pdf
2016-08-30,恒瑞医药第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_2.pdf
2016-08-30,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2016-08-30/600276_20160830_8.pdf
2016-08-30,恒瑞医药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-30/600276_2016_zzy.pdf
2016-08-30,恒瑞医药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-30/600276_2016_z.pdf
2016-09-09,恒瑞医药关于子公司获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-09-09/600276_20160909_1.pdf
2016-09-15,恒瑞医药关于回购股份的进展公告,/disclosure/listedinfo/announcement/c/2016-09-15/600276_20160915_1.pdf
2016-09-20,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-09-20/600276_20160920_1.pdf
2016-10-15,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-10-15/600276_20161015_1.pdf
2016-10-20,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600276_20161020_2.pdf
2016-10-20,恒瑞医药关于获得新药证书和药品注册批件的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600276_20161020_1.pdf
2016-10-27,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-10-27/600276_20161027_1.pdf
2016-10-29,恒瑞医药关于授权利用闲置自有资金投资低风险理财产品的公告,/disclosure/listedinfo/announcement/c/2016-10-29/600276_20161029_3.pdf
2016-10-29,恒瑞医药独立董事关于授权利用闲置自有资金投资低风险理财产品的独立意见,/disclosure/listedinfo/announcement/c/2016-10-29/600276_20161029_5.pdf
2016-10-29,恒瑞医药第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-29/600276_20161029_2.pdf
2016-10-29,恒瑞医药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-29/600276_2016_3.pdf
2016-11-04,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-04/600276_20161104_1.pdf
2016-11-11,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-11/600276_20161111_1.pdf
2016-11-16,恒瑞医药关于公司及控股子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2016-11-16/600276_20161116_1.pdf
2016-11-17,恒瑞医药关于公司及控股子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2016-11-17/600276_20161117_1.pdf
2016-11-19,恒瑞医药关于子公司获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-19/600276_20161119_1.pdf
2016-12-01,恒瑞医药关于签署许可协议的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600276_20161201_1.pdf
2016-12-03,恒瑞医药关于签署许可协议的补充公告,/disclosure/listedinfo/announcement/c/2016-12-03/600276_20161203_1.pdf
2016-12-07,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2016-12-07/600276_20161207_2.pdf
2016-12-07,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-12-07/600276_20161207_1.pdf
2016-12-28,恒瑞医药关于获得审批意见通知件的公告,/disclosure/listedinfo/announcement/c/2016-12-28/600276_20161228_1.pdf
2017-01-05,恒瑞医药监事会关于部分股权激励股票第二次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2017-01-05/600276_20170105_4.pdf
2017-01-05,恒瑞医药独立董事关于公司部分股权激励股票第二次解锁的独立意见,/disclosure/listedinfo/announcement/c/2017-01-05/600276_20170105_3.pdf
2017-01-05,恒瑞医药第七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-05/600276_20170105_1.pdf
2017-01-05,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励解锁事项的法律意见,/disclosure/listedinfo/announcement/c/2017-01-05/600276_20170105_2.pdf
2017-01-07,恒瑞医药关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-07/600276_20170107_1.pdf
2017-01-10,恒瑞医药监事会关于部分股权激励股票第二次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2017-01-10/600276_20170110_4.pdf
2017-01-10,恒瑞医药关于部分股权激励股票第二次解锁的公告,/disclosure/listedinfo/announcement/c/2017-01-10/600276_20170110_1.pdf
2017-01-10,恒瑞医药独立董事关于公司部分股权激励股票第二次解锁的独立意见,/disclosure/listedinfo/announcement/c/2017-01-10/600276_20170110_3.pdf
2017-01-10,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励解锁事项的法律意见,/disclosure/listedinfo/announcement/c/2017-01-10/600276_20170110_2.pdf
2017-01-17,恒瑞医药关于获得药物临床试验通知的公告,/disclosure/listedinfo/announcement/c/2017-01-17/600276_20170117_2.pdf
2017-01-17,恒瑞医药关于公司及控股子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-01-17/600276_20170117_1.pdf
2017-01-25,恒瑞医药关于获得药物临床试验通知的公告,/disclosure/listedinfo/announcement/c/2017-01-25/600276_20170125_1.pdf
2017-02-08,恒瑞医药关于获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-02-08/600276_20170208_1.pdf
2017-02-09,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-02-09/600276_20170209_1.pdf
2017-02-09,恒瑞医药关于获得新药证书和药品注册批件的公告,/disclosure/listedinfo/announcement/c/2017-02-09/600276_20170209_2.pdf
2017-02-21,恒瑞医药关于子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-02-21/600276_20170221_2.pdf
2017-02-21,恒瑞医药关于获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-02-21/600276_20170221_1.pdf
2017-02-27,恒瑞医药关于公司主要产品新进入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-27/600276_20170227_5.pdf
2017-02-27,恒瑞医药关于公司董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-02-27/600276_20170227_6.pdf
2017-03-09,恒瑞医药关于公司及子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-03-09/600276_20170309_1.pdf
2017-03-09,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2017-03-09/600276_20170309_3.pdf
2017-03-11,恒瑞医药章程修正案,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_4.pdf
2017-03-11,恒瑞医药审计委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_14.pdf
2017-03-11,恒瑞医药关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_3.pdf
2017-03-11,恒瑞医药关于调整利用闲置自有资金购买理财产品授权额度及所购买理财产品的发行主体范围的公告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_17.pdf
2017-03-11,恒瑞医药公司章程（2017年修订）,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_15.pdf
2017-03-11,恒瑞医药独立董事关于第七届董事会第七次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_8.pdf
2017-03-11,恒瑞医药第七届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_5.pdf
2017-03-11,恒瑞医药第七届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_6.pdf
2017-03-11,恒瑞医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_13.pdf
2017-03-11,恒瑞医药：关于江苏恒瑞医药股份有限公司2016年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_10.pdf
2017-03-11,恒瑞医药：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_9.pdf
2017-03-11,恒瑞医药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-11/600276_2016_nzy.pdf
2017-03-11,恒瑞医药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_2016_n.pdf
2017-03-11,恒瑞医药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_19.pdf
2017-03-11,恒瑞医药2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-03-11/600276_20170311_11.pdf
2017-03-16,恒瑞医药关于获得药物上市许可的公告,/disclosure/listedinfo/announcement/c/2017-03-16/600276_20170316_1.pdf
2017-03-23,恒瑞医药关于召开2016年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2017-03-23/600276_20170323_2.pdf
2017-03-23,恒瑞医药2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-03-23/600276_20170323_1.pdf
2017-03-29,恒瑞医药关于获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600276_20170329_1.pdf
2017-04-01,恒瑞医药关于股东权益变动的进展公告,/disclosure/listedinfo/announcement/c/2017-04-01/600276_20170401_1.pdf
2017-04-07,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-04-07/600276_20170407_1.pdf
2017-04-10,恒瑞医药2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-10/600276_20170410_1.pdf
2017-04-10,恒瑞医药2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-10/600276_20170410_2.pdf
2017-04-14,恒瑞医药关于在江苏投资设立子公司的公告,/disclosure/listedinfo/announcement/c/2017-04-14/600276_20170414_2.pdf
2017-04-14,恒瑞医药第七届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-14/600276_20170414_1.pdf
2017-04-19,恒瑞医药关于获得药物临床试验通知的公告,/disclosure/listedinfo/announcement/c/2017-04-19/600276_20170419_1.pdf
2017-04-21,恒瑞医药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-21/600276_2017_1.pdf
2017-05-04,恒瑞医药关于获得药物临床试验通知的公告,/disclosure/listedinfo/announcement/c/2017-05-04/600276_20170504_1.pdf
2017-05-05,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2017-05-05/600276_20170505_1.pdf
2017-05-05,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-05-05/600276_20170505_4.pdf
2017-05-05,恒瑞医药独立董事关于回购注销部分已授出股权激励股票的独立意见,/disclosure/listedinfo/announcement/c/2017-05-05/600276_20170505_2.pdf
2017-05-05,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司回购注销部分限制性股票的法律意见,/disclosure/listedinfo/announcement/c/2017-05-05/600276_20170505_3.pdf
2017-05-22,恒瑞医药2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-05-22/600276_20170522_1.pdf
2017-05-24,恒瑞医药关于开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2017-05-24/600276_20170524_2.pdf
2017-05-24,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-05-24/600276_20170524_1.pdf
2017-06-10,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_6.pdf
2017-06-10,恒瑞医药关于调整限制性股票回购数量及回购价格的公告,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_3.pdf
2017-06-10,恒瑞医药独立董事关于第七届董事会第十一次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_4.pdf
2017-06-10,恒瑞医药第七届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_2.pdf
2017-06-10,恒瑞医药第七届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_1.pdf
2017-06-10,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励调整事项的法律意见,/disclosure/listedinfo/announcement/c/2017-06-10/600276_20170610_5.pdf
2017-06-27,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600276_20170627_1.pdf
2017-06-27,恒瑞医药关于公司及控股子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600276_20170627_2.pdf
2017-06-29,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2017-06-29/600276_20170629_1.pdf
2017-07-12,恒瑞医药关于回购注销部分已授出股权激励股票的公告,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_5.pdf
2017-07-12,恒瑞医药关于回购注销部分限制性股票通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_6.pdf
2017-07-12,恒瑞医药独立董事关于第七届董事会第十二次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_2.pdf
2017-07-12,恒瑞医药第七届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_4.pdf
2017-07-12,恒瑞医药第七届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_1.pdf
2017-07-12,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励相关事项的法律意见,/disclosure/listedinfo/announcement/c/2017-07-12/600276_20170712_3.pdf
2017-07-15,恒瑞医药关于获得药物上市许可的公告,/disclosure/listedinfo/announcement/c/2017-07-15/600276_20170715_3.pdf
2017-07-15,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-07-15/600276_20170715_2.pdf
2017-07-20,恒瑞医药关于部分股权激励股票第三次解锁的公告,/disclosure/listedinfo/announcement/c/2017-07-20/600276_20170720_1.pdf
2017-07-21,恒瑞医药关于公司主要产品新进入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-07-21/600276_20170721_1.pdf
2017-07-25,恒瑞医药关于公司主要产品新进入国家医保目录的补充公告,/disclosure/listedinfo/announcement/c/2017-07-25/600276_20170725_1.pdf
2017-07-28,恒瑞医药关于开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2017-07-28/600276_20170728_1.pdf
2017-08-05,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-08-05/600276_20170805_1.pdf
2017-08-05,恒瑞医药关于公司及子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2017-08-05/600276_20170805_2.pdf
2017-08-15,恒瑞医药关于获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-08-15/600276_20170815_2.pdf
2017-08-15,恒瑞医药关于公司及子公司开展药物临床试验的公告,/disclosure/listedinfo/announcement/c/2017-08-15/600276_20170815_1.pdf
2017-08-30,恒瑞医药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-30/600276_2017_zzy.pdf
2017-08-30,恒瑞医药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-30/600276_2017_z.pdf
2017-09-05,恒瑞医药关于获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-09-05/600276_20170905_1.pdf
2017-09-12,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2017-09-12/600276_20170912_1.pdf
2017-09-22,恒瑞医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2017-09-22/600276_20170922_1.pdf
2017-09-27,恒瑞医药澄清公告,/disclosure/listedinfo/announcement/c/2017-09-27/600276_20170927_1.pdf
2017-10-09,恒瑞医药关于公司产品注册申请进展的说明公告,/disclosure/listedinfo/announcement/c/2017-10-09/600276_20171009_1.pdf
2017-10-19,恒瑞医药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-19/600276_2017_3.pdf
2017-11-01,恒瑞医药限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_7.pdf
2017-11-01,恒瑞医药关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_9.pdf
2017-11-01,恒瑞医药关于公司董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_12.pdf
2017-11-01,恒瑞医药关于独立董事公开征集投票权的公告,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_10.pdf
2017-11-01,恒瑞医药独立董事关于2017年度限制性股票激励计划（草案）及相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_3.pdf
2017-11-01,恒瑞医药第七届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_11.pdf
2017-11-01,恒瑞医药第七届监事会第十二次会议决议,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_5.pdf
2017-11-01,恒瑞医药第七届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_1.pdf
2017-11-01,恒瑞医药：北京市中伦律师事务所关于《江苏恒瑞医药股份有限公司2017年度限制性股票激励计划（草案）》的法律意见,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_4.pdf
2017-11-01,恒瑞医药2017年度限制性股票激励计划实施考核管理办法,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_6.pdf
2017-11-01,恒瑞医药2017年度限制性股票激励计划（草案）摘要,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_2.pdf
2017-11-01,恒瑞医药2017年度限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2017-11-01/600276_20171101_8.pdf
2017-11-04,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-11-04/600276_20171104_1.pdf
2017-11-07,恒瑞医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-11-07/600276_20171107_1.pdf
2017-11-10,恒瑞医药关于2017年第一次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-11-10/600276_20171110_3.pdf
2017-11-10,恒瑞医药独立董事关于第七届董事会第十六次会议有关事项的意见,/disclosure/listedinfo/announcement/c/2017-11-10/600276_20171110_2.pdf
2017-11-10,恒瑞医药第七届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-10/600276_20171110_1.pdf
2017-11-16,恒瑞医药2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-16/600276_20171116_1.pdf
2017-11-18,恒瑞医药监事会关于2017年度限制性股票激励计划激励对象人员名单的审核意见及公示情况说明,/disclosure/listedinfo/announcement/c/2017-11-18/600276_20171118_1.pdf
2017-11-24,恒瑞医药关于2017年度限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告,/disclosure/listedinfo/announcement/c/2017-11-24/600276_20171124_3.pdf
2017-11-24,恒瑞医药2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-24/600276_20171124_1.pdf
2017-11-24,恒瑞医药2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-11-24/600276_20171124_2.pdf
2017-11-25,恒瑞医药限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_6.pdf
2017-11-25,恒瑞医药关于向公司2017年度限制性股票激励计划激励对象首次授予限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_3.pdf
2017-11-25,恒瑞医药独立董事关于第七届董事会第十七次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_4.pdf
2017-11-25,恒瑞医药第七届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_2.pdf
2017-11-25,恒瑞医药第七届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_1.pdf
2017-11-25,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司2017年度限制性股票激励计划首次授予的法律意见,/disclosure/listedinfo/announcement/c/2017-11-25/600276_20171125_5.pdf
2017-11-29,恒瑞医药关于获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-11-29/600276_20171129_1.pdf
2017-12-06,恒瑞医药关于获得美国FDA国际多中心临床试验资格的公告,/disclosure/listedinfo/announcement/c/2017-12-06/600276_20171206_1.pdf
2017-12-11,恒瑞医药关于公司产品完成II期临床试验的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-11/600276_20171211_1.pdf
2017-12-14,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-12-14/600276_20171214_1.pdf
2017-12-30,恒瑞医药关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600276_20171230_1.pdf
2018-01-05,恒瑞医药关于许可美国Arcutis公司在国外开发和销售JAK1抑制剂的公告,/disclosure/listedinfo/announcement/c/2018-01-05/600276_20180105_1.pdf
2018-01-08,恒瑞医药关于签署许可协议的补充公告,/disclosure/listedinfo/announcement/c/2018-01-08/600276_20180108_1.pdf
2018-01-10,恒瑞医药关于与美国TG公司签订许可协议的公告,/disclosure/listedinfo/announcement/c/2018-01-10/600276_20180110_2.pdf
2018-01-10,恒瑞医药关于签署许可协议的补充公告,/disclosure/listedinfo/announcement/c/2018-01-10/600276_20180110_1.pdf
2018-01-11,恒瑞医药监事会关于部分股权激励股票第三次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2018-01-11/600276_20180111_3.pdf
2018-01-11,恒瑞医药独立董事关于公司部分股权激励股票第三次解锁的独立意见,/disclosure/listedinfo/announcement/c/2018-01-11/600276_20180111_4.pdf
2018-01-11,恒瑞医药第七届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-11/600276_20180111_1.pdf
2018-01-11,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励相关事项的法律意见,/disclosure/listedinfo/announcement/c/2018-01-11/600276_20180111_2.pdf
2018-01-17,恒瑞医药关于获得审批意见通知件和药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2018-01-17/600276_20180117_1.pdf
2018-01-17,恒瑞医药关于获得美国FDA药品临床试验资格的公告,/disclosure/listedinfo/announcement/c/2018-01-17/600276_20180117_2.pdf
2018-01-20,恒瑞医药关于2017年度限制性股票激励计划首次授予结果的公告,/disclosure/listedinfo/announcement/c/2018-01-20/600276_20180120_1.pdf
2018-01-23,恒瑞医药：验资报告,/disclosure/listedinfo/announcement/c/2018-01-23/600276_20180123_1.pdf
2018-01-26,恒瑞医药监事会关于部分股权激励股票第三次解锁的书面审核意见,/disclosure/listedinfo/announcement/c/2018-01-26/600276_20180126_4.pdf
2018-01-26,恒瑞医药关于部分股权激励股票第三次解锁的公告,/disclosure/listedinfo/announcement/c/2018-01-26/600276_20180126_1.pdf
2018-01-26,恒瑞医药独立董事关于公司部分股权激励股票第三次解锁的独立意见,/disclosure/listedinfo/announcement/c/2018-01-26/600276_20180126_3.pdf
2018-01-26,恒瑞医药：北京市中伦律师事务所关于江苏恒瑞医药股份有限公司股权激励相关事项的法律意见,/disclosure/listedinfo/announcement/c/2018-01-26/600276_20180126_2.pdf
2018-01-31,恒瑞医药关于公司产品拟纳入优先审评程序的公告,/disclosure/listedinfo/announcement/c/2018-01-31/600276_20180131_1.pdf
2018-02-15,恒瑞医药关于许可美国 Incyte 公司在国外开发和销售PD-1抗体项目进展的提示性公告,/disclosure/listedinfo/announcement/c/2018-02-15/600276_20180215_1.pdf
